Security personnel stands guard during restrictions and strike called by separatists after the killing of PhD scholar-turned-Hizbul Mujahideen commander Manaan Bashir Wani. (Photo| PTI) 
India

Separatist shutdown affects life in Kashmir Valley

Authorities have imposed restrictions in Maisuma, Rainawari, Khanyar, M.R. Gunj and Safa Kadal areas of Srinagar city.

From our online archive

SRINAGAR: Life across the Kashmir Valley was affected on Friday due to a separatist-called protest shutdown against the detention of Jammu and Kashmir Liberation Front (JKLF) chairman Muhammad Yasin Malik and also the arrest of Jamaat-e-Islami (JI) cadres.

The shutdown was called by the Joint Resistance Leadership (JRL), a separatist conglomerate headed by Syed Ali Geelani, Mirwaiz Umer Farooq and Yasin Malik.

Authorities have imposed restrictions in Maisuma, Rainawari, Khanyar, M.R. Gunj and Safa Kadal areas of Srinagar city. Mirwaiz Umer Farooq has been placed under house arrest in residence.

Geelani continues to remain under house arrest in Hyderpora locality of Srinagar. Shops, public transport and other businesses remained shut across the valley.

Heavy contingents of state police and the Central Reserve Police Force (CRPF) have been deployed in law and order sensitive areas.

Malik was detained under the Public Safety Act (PSA) on Thursday and was shifted to the Kot Balwal Jail in Jammu district. Anybody detained under the PSA can be held for a maximum of two years without any judicial intervention.

Some of the recently detained senior JI leaders have also been booked under the PSA and were shifted to jails outside the valley.

Why the additional declaration linked to Form 6 is facing a legal challenge

SP-Congress alliance faces fresh strain as Akhilesh skips INDIA bloc meet over UP seat-sharing talks

Rahul Gandhi tells CWC to continue 'resistance' against 'match-fixing' of polls through EVM, voters list

Assam Rifles jawan killed in militant attack in Arunachal; security forces intensify ops to arrest killers

SC slams medicine pricing, calls cancer drug’s 10-fold MRP markup ‘carnage’